Geara F, Le Bourgeois J P, Piedbois P, Haddad E, Levy E, Taghian A
Ann Radiol (Paris). 1989;32(2):112-6.
Between June 1986 and August 1988, 129 patients with AIDS-related Kaposi's sarcoma were treated by cutaneous irradiation in our department. According to Mitsuyasu's staging, 25 patients (19%) were stage 1.76 (59%) stage II, no stage III was reported and 28 (22%) stage IV. Fifty four patients (42%) had previously presented with one or multiple opportunistic infections. Eighty six (66%) had previously received treatment: by interferon in 80 patients (62%) and/or Velbe in 40 (31%). Seventy six patients (59%) were treated by extensive cutaneous irradiation using 4 and/or 8 MeV electron beam energy and 53 patients (41%) by localized irradiation using 45 kV X-ray energy, 2.5 Gy/fraction, 4 times/week by split course 20 Gy then 10 Gy two weeks later. Only 111 patients were evaluable; 61% obtained complete remission and 33% partial remission after a mean period of 1.5 months (0.5-3 months). The overall tolerance was acceptable. The complications were epidermitis with some necrosis (8%), exudative epidermitis (26%) moderate epidermitis (63%) and slight reactions in 4%. The mean recurrence time was 5 1/2 months.
1986年6月至1988年8月期间,我科对129例艾滋病相关卡波西肉瘤患者进行了皮肤照射治疗。根据光保靖的分期,25例(19%)为1期,76例(59%)为2期,未报告3期患者,28例(22%)为4期。54例(42%)患者此前曾出现过一次或多次机会性感染。86例(66%)患者此前接受过治疗:80例(62%)使用过干扰素和/或40例(31%)使用过威布尔。76例(59%)患者接受了使用4和/或8兆电子伏特电子束能量的广泛皮肤照射,53例(41%)患者接受了使用45千伏X射线能量的局部照射,每次分割剂量2.5戈瑞,每周4次,分程照射,先照射20戈瑞,两周后再照射10戈瑞。只有111例患者可进行评估;平均1.5个月(0.5 - 3个月)后,61%的患者获得完全缓解,33%的患者获得部分缓解。总体耐受性可以接受。并发症包括伴有一些坏死的表皮炎(8%)、渗出性表皮炎(26%)、中度表皮炎(63%)以及4%的轻微反应。平均复发时间为5个半月。